84 results on '"F Hitzenbichler"'
Search Results
2. Schweres therapierefraktäres Lungenversagen bei COVID-19: Stellenwert und Problematik einer Langzeitunterstützung mit ceno-venöser extrakorporaler Membranoxygenierung Eine retrospektive Analyse des ECMO Zentrum Regensburg
- Author
-
C Wiest, A Philipp, D Lunz, J Steinmann, C Eissnert, M Kees, M Kieninger, T Dienemann, M Ritzka, S Schweiger, A Pross, C Fisser, M Malfertheiner, R Schneckenpointner, T Lange, C Schulz, F Geismann, M Foltan, F Schettler, B Salzberger, F Hitzenbichler, F Hanses, B Schmidt, M Arzt, S Barbara, B Graf, L Maier, T Müller, and M Lubnow
- Published
- 2023
- Full Text
- View/download PDF
3. Einfluss des selektiven Antibiogramms auf die antibiotische Therapie bei Patienten mit Blutstrominfektionen mit Streptococcus pneumoniae
- Author
-
F Geismann, K Brückner, M Pfeifer, B Salzberger, S Bauernfeind, F Hitzenbichler, M Simon, A Caplunik-Pratsch, W Schneider, C Wiest, T Rügamer, and A Mohr
- Published
- 2023
- Full Text
- View/download PDF
4. Einfluss der Anwendung unterschiedlicher Atemschutzmasken auf Leistungsfähigkeit, Dyspnoe und Blutgasanalysen bei Gesunden, Rauchern und Patienten mit interstitieller Lungenerkrankung
- Author
-
S Zahn, F Hitzenbichler, F Geismann, S Blaas, M Pfeifer, M Malfertheiner, B Salzberger, F Hanses, S Bauernfeind, and A Mohr
- Published
- 2023
- Full Text
- View/download PDF
5. [Epidemiology of SARS-CoV-2 infection and COVID-19]
- Author
-
B, Salzberger, F, Buder, B, Lampl, B, Ehrenstein, F, Hitzenbichler, and F, Hanses
- Subjects
China ,Basisreproduktionszahl ,SARS-CoV-2 ,Pneumonia, Viral ,„Severe acute respiratory syndrome coronavirus 2“ (SARS-CoV-2) ,Inkubationsphase ,Basic Reproduction Number ,COVID-19 ,Virus Replication ,Mortality rate ,“Coronavirus disease 2019” (COVID-19)/epidemiology ,„Coronavirus disease 2019“ (COVID-19)/Epidemiologie ,Letalität ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Betacoronavirus ,Risk Factors ,Communicable Disease Control ,Humans ,Incubation period ,Coronavirus Infections ,Schwerpunkt: COVID-19 ,Pandemics - Abstract
Das „severe acute respiratory syndrome coronavirus 2“ (SARS-CoV-2) ist ein neues β‑Coronavirus, das Ende 2019 in Wuhan, China, erstmals entdeckt wurde und sich in den folgenden Monaten weltweit verbreitete. Wir stellen hier die bisher bekannten Parameter und Daten zur Epidemiologie des Virus dar. SARS-CoV‑2 repliziert vor allem im oberen und unteren Respirationstrakt und wird überwiegend von asymptomatisch wie symptomatisch Infizierten durch Tröpfchen übertragen. Die Basisreproduktionszahl wird derzeit auf einen Wert zwischen 2 und 3 geschätzt, die Inkubationszeit beträgt im Median 6 (2–14) Tage. Die überwiegende Zahl der Infektionen verläuft unkompliziert, bei 5–10 % der Infizierten tritt eine Pneumonie auf, die zur Hospitalisierung und auch zum Organversagen führen kann. Wichtigste Risikofaktoren für einen komplizierten Verlauf sind höheres Alter, Hypertonie und chronische Herz- und Lungenerkrankungen sowie Immundefekte. Nosokomiale Übertragungen und Infektionen bei medizinischem Personal werden beobachtet. Die „case fatality rate“ über alle Altersgruppen beträgt etwa 1,4 %, sie steigt ab der sechsten Lebensdekade an. Mit der Reduktion von sozialen Kontakten sind bisher in vielen Regionen Ausbrüche begrenzt worden. Welche Maßnahmen im Einzelnen wirksam sind, ist noch offen.
- Published
- 2020
6. Orthotopic Liver Transplantation in Human-Immunodeficiency-Virus-Positive Patients in Germany
- Author
-
E. Anadol, S. Beckebaum, K. Radecke, A. Paul, A. Zoufaly, M. Bickel, F. Hitzenbichler, T. Ganten, J. Kittner, M. Stoll, C. Berg, S. Manekeller, J. C. Kalff, T. Sauerbruch, J. K. Rockstroh, and U. Spengler
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Abstract
Objectives. This summary evaluates the outcomes of orthotopic liver transplantation (OLT) of HIV-positive patients in Germany. Methods. Retrospective chart analysis of HIV-positive patients, who had been liver-transplanted in Germany between July 1997 and July 2011. Results. 38 transplantations were performed in 32 patients at 9 German transplant centres. The reasons for OLT were end-stage liver disease (ESLD) and/or liver failure due to hepatitis C (HCV) (𝑛=19), hepatitis B (HBV) (𝑛=10), multiple viral infections of the liver (𝑛=2) and Budd-Chiari-Syndrome. In July 2011 19/32 (60%) of the transplanted patients were still alive with a median survival of 61 months (IQR (interquartile range): 41–86 months). 6 patients had died in the early post-transplantation period from septicaemia (𝑛=4), primary graft dysfunction (𝑛=1), and intrathoracal hemorrhage (𝑛=1). Later on 7 patients had died from septicaemia (𝑛=2), delayed graft failure (𝑛=2), recurrent HCC (𝑛=2), and renal failure (𝑛=1). Recurrent HBV infection was efficiently prevented in 11/12 patients; HCV reinfection occurred in all patients and contributed considerably to the overall mortality. Conclusions. Overall OLT is a feasible approach in HIV-infected patients with acceptable survival rates in Germany. Reinfection with HCV still remains a major clinical challenge in HIV/HCV coinfection after OLT.
- Published
- 2012
- Full Text
- View/download PDF
7. Peritoneale Tuberkulose
- Author
-
S Dostert, F. Hitzenbichler, B. Seelbach-Göbel, and A. Schnabel
- Subjects
medicine.medical_specialty ,Reproductive Medicine ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Obstetrics and Gynecology ,business ,Gastroenterology ,Peritoneal tuberculosis - Published
- 2017
- Full Text
- View/download PDF
8. [Current treatment of endocarditis : Innovations and controversies]
- Author
-
F, Hitzenbichler, J, Olic, F, Hanses, B, Salzberger, M, Fischer, and A, Baessler
- Subjects
Adult ,Endocarditis ,Mycoses ,Incidence ,Humans ,Comorbidity ,Endocarditis, Bacterial ,Gram-Negative Bacterial Infections ,Gram-Positive Bacterial Infections ,Anti-Bacterial Agents - Abstract
Despite many novel diagnostic strategies and advances in treatment, infective endocarditis (IE) remains a severe disease. The epidemiology of IE has shifted and staphylococci have replaced streptococci as the most common cause and nosocomially acquired infections, invasive procedures, indwelling cardiac devices and acquired infections due to intravenous drug abuse are more frequent. The incidence of IE has steadily increased in recent years and the patients affected are older and have more comorbidities. The modern treatment of IE is interdisciplinary. The pharmacotherapy of IE depends on the pathogen and its sensitivity. The presence of a bioprosthetic valve and implantable cardiac devices plays a significant role in selection of antibiotics and duration of treatment. This article provides an update and overview of the current clinical practice in diagnostics and pharmacotherapy of IE in adults with a special focus on partial oral therapy and the role of aminoglycosides.
- Published
- 2019
9. [Pneumocystis jirovecii pneumonia-an opportunistic infection undergoing change]
- Author
-
F, Hitzenbichler, A, Mohr, and B, Salzberger
- Subjects
Pneumocystis Infections ,Immunocompromised Host ,Pneumonia, Pneumocystis ,Trimethoprim, Sulfamethoxazole Drug Combination ,Humans ,HIV Infections ,Opportunistic Infections ,Pneumocystis carinii ,Anti-Bacterial Agents - Abstract
Pneumocystis jirovecii pneumonia (PcP) has for many years been reported mostly in human immunodeficiency virus-infected patients. Increasingly, it also affects other immunocompromised patients, e.g. after organ or allogeneic stem cell/bone marrow transplantation, patients with hematologic malignancies or autoimmune diseases. The diagnosis of PcP relies on a critical evaluation of clinical symptoms, risk factors, radiologic features and microbiological tests. High dose cotrimoxazole is the most effective therapeutic option. Rapid initiation is essential, since mortality is especially high in patients admitted to intensive care with respiratory failure. This article reviews the current epidemiology of PcP and highlights the diagnostic and therapeutic options. Recommendations for primary and secondary prophylaxis are summarized.
- Published
- 2019
10. [Influenza : How to vaccinate?]
- Author
-
B, Salzberger, F, Hitzenbichler, and G, Birkenfeld
- Subjects
Adult ,Aged, 80 and over ,Male ,Adolescent ,Patient Selection ,Infant ,Middle Aged ,Mass Vaccination ,Young Adult ,Influenza Vaccines ,Child, Preschool ,Germany ,Influenza, Human ,Practice Guidelines as Topic ,Humans ,Female ,Child ,Aged - Published
- 2016
11. Hepatitis E virus infection in immunosuppressed patients and its clinical manifestations.
- Author
-
Kupke P, Kupke M, Borgmann S, Kandulski A, Hitzenbichler F, Menzel J, Geissler EK, Schlitt HJ, Wenzel JJ, and Werner JM
- Subjects
- Humans, Male, Retrospective Studies, Female, Middle Aged, Adult, Risk Factors, Aged, RNA, Viral, Immunoglobulin M blood, Organ Transplantation adverse effects, Immunosuppressive Agents adverse effects, Immunosuppressive Agents therapeutic use, Hepatitis Antibodies blood, Enzyme-Linked Immunosorbent Assay, Hepatitis E immunology, Hepatitis E diagnosis, Immunocompromised Host, Hepatitis E virus immunology, Hepatitis E virus genetics
- Abstract
Background & Aims: Hepatitis E virus (HEV) is a main cause of acute hepatitis globally. However, immunosuppressed patients regularly develop chronic courses. The aim of this study was to analyse the current status of HEV diagnostics, characterize clinical manifestations and identify risk factors for complicated HEV infections., Methods: In this retrospective study at two large hospitals, 512 patients with borderline and positive anti-HEV-IgM and 94 patients with positive HEV-PCR between January 1999 and May 2023 were included., Results: Detection by anti-HEV-IgM-ELISA led to a positive HEV-PCR in only 17.9 %. Amongst patients with positive HEV-PCR, 61 had underlying immunosuppression and 23 were patients after solid organ transplantation (SOT). All 13 patients with chronic HEV infections were immunosuppressed. Generally, immunosuppression led to higher HEV-RNA concentrations and a higher probability of receiving immediate treatment. However, all fulminant courses with liver failure happened in patients without immunosuppression. Immunocompetent patients showed symptoms more frequently and primarily had higher bilirubin levels indicating more severe liver damage. A risk factor for delayed or failed viral clearance after SOT was the administration of mTOR inhibitors., Conclusions: Fulminant HEV infections happen primarily in immunocompetent patients. Nevertheless, immunosuppressed patients bear the risk of undetected, prolonged HEV infections, reflected by the rare occurrence of symptoms., Competing Interests: Conflict of interest The authors have no conflicts of interest to declare., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
12. Is the use of antibiotic stewardship measures in the context of specialized outpatient palliative care sensible and feasible? An interview-based study.
- Author
-
Kaiser U, Kaiser F, Schmidt J, Vehling-Kaiser U, and Hitzenbichler F
- Subjects
- Humans, Germany, Ambulatory Care methods, Ambulatory Care standards, Interviews as Topic methods, Anti-Bacterial Agents therapeutic use, Female, Male, Middle Aged, Palliative Care methods, Palliative Care standards, Antimicrobial Stewardship methods, Antimicrobial Stewardship standards, Qualitative Research
- Abstract
Background: Specialized outpatient palliative care (SAPV) is a component of palliative care in Germany, which assists approximately 10% of palliative patients. The majority of these patients have a malignant disease and are at increased risk of complications or severe infection. Antibiotic stewardship (ABS) measures are implemented to optimize antibiotic administration; however, there is little data available in this area, particularly for SAPV. Therefore, we examined the extent to which ABS measures can be meaningfully used or implemented in SAPV., Methods: After establishing a corresponding interview guide, 15 experts from specialized areas were interviewed on this subject by the Institute for Market Research in Healthcare Munich (IMIG) through audio-registered individual interviews. The interviews were analyzed using the qualitative content analysis method according to Mayring., Results: All 15 experts participated. The primary benefits cited were greater safety in the prescription and decision-making process for antibiotics in the areas of SAPV and improved quality of life. The implementation of continuous ABS measures for SAPV was considered difficult in some cases and linked to certain prerequisites, such as supportive advice from existing systems. The possibility of further training for SAPV members in the area of ABS was considered particularly advantageous., Conclusions: The implementation of ABS measures in SAPV is feasible in principle; however, it is difficult to implement under the current conditions. Close cooperation with an existing external ABS expert/team will be helpful. This will provide more security for a small, but relevant proportion of SAPV patients, and for the SAPV team treating them., Competing Interests: Declarations. Ethics approval and consent to participate: After consultation with the Ethics Committee of the University of Regensburg, no professional advice and consequently no vote by the Ethics Committee was required for the present study in accordance with Sect. 15 of the Professional Code of Conduct for Physicians in Bavaria. Consent for publication: Not applicable. Competing interests: U.K., J.S., and U.VK. declare no competing interests; F.H. has received lecture fees from Pfizer, and travel expenses and congress fees have been covered by Tillotts Pharma and Gilead Sciences; F.K. has conducted consulting work for Elsevier, Astellas, GSK, MSD, Novartis, Pierre Fabre, Sanofi, and Servier., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
13. Traumatic Complete Loss of Knee Extensor Mechanism and Its Reconstruction With a Fresh-frozen Patellar Allograft With Patellar and Quadriceps Tendon.
- Author
-
Weber J, Kerschbaum M, Klein S, Hitzenbichler F, Rupp M, and Alt V
- Abstract
We report on an 18-year-old female who sustained complete loss of her knee extensor mechanism (patella, quadriceps and patellar tendon) due to a motorbike injury with severe soft tissue loss of the ventral aspect of the knee and subsequent infection. After infection control and successful latissimus dorsi free flap surgery, reconstruction of the knee extensor mechanism was performed using a fresh frozen extensor mechanism allograft with patella, quadriceps- and patellar tendon and integrated tibia tuberosity fragment. After a follow-up of 18 months, there was infection free integration of the allograft with a range of motion 0-0-90° (extension/flexion) and pain free gait., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
- Published
- 2024
- Full Text
- View/download PDF
14. Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases.
- Author
-
Schuderer JG, Hoferer F, Eichberger J, Fiedler M, Gessner A, Hitzenbichler F, Gottsauner M, Maurer M, Meier JK, Reichert TE, and Ettl T
- Subjects
- Humans, Male, Female, Retrospective Studies, Middle Aged, Aged, Adult, Perioperative Care methods, Surgical Wound Infection prevention & control, Antibiotic Prophylaxis methods, Plastic Surgery Procedures methods, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Head and Neck Neoplasms surgery, Free Tissue Flaps blood supply
- Abstract
Literature suggests that intravenous prophylaxis exceeding 48 h offers no additional benefit in preventing surgical site infections (SSI) in patients with microvascular head and neck reconstruction. However, protocols for antibiotic therapy duration post-reconstruction are not standardized. This study identifies factors predicting prolonged intravenous antibiotic use and antibiotic escalation in patients receiving free flap head neck reconstruction. A retrospective analysis of 446 patients receiving free flap reconstruction was conducted, examining predictors for antibiotic therapy > 10 days and postoperative escalation. 111 patients (24.8%) experienced escalation, while 159 patients (35.6%) received prolonged therapy. Multivariate regression analysis revealed predictors for escalation: microvascular bone reconstruction (p = 0.008, OR = 2.0), clinically suspected SSI (p < 0.001, OR = 5.4), culture-positive SSI (p = 0.03, OR = 2.9), extended ICU stay (p = 0.01, OR = 1.1) and hospital-acquired pneumonia (p = 0.01, OR = 5.9). Prolonged therapy was associated with bone reconstruction (p = 0.06, OR = 2.0), preoperative irradiation (p = 0.001, OR = 1.9) and culture-positive SSI (p < 0.001, OR = 3.5). The study concludes that SSIs are a primary factor driving the escalation of perioperative antibiotic use. Clinical suspicion of infection often necessitates escalation, even in the absence of confirmed microbiological evidence. Microvascular bone reconstruction was a significant predictor for both the escalation and extension of antibiotic therapy beyond 10 days. Furthermore, preoperative radiation therapy, hospital-acquired pneumonia, and prolonged ICU stay were associated with an increased likelihood of escalation, resulting in significantly extended antibiotic administration during hospitalization. Antibiotic stewardship programmes must be implemented to reduce postoperative antibiotic administration time.Trial registration The study was registered approved by the local Ethics Committee (Nr: 18-1131-104)., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
15. Infection image: cystic pneumocystis jirovecii pneumonia - forgotten?
- Author
-
Hitzenbichler F, Fisser C, Schlitt A, and Salzberger B
- Abstract
A 43-year-old male patient presented to the emergency department with progressive dyspnea. CT scan showed pronounced cystic lesions and ground glass opacitiy in both lungs and diagnosis of HIV infection was established. Bronchoscopy confirmed diagnosis of pneumocystis jirovecii pneumonia (PCP). The radiological presentation with perihilar large cysts is typical for PCP in HIV-infected patients, but rarely encountered today., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
16. Clinical Characterization of Pathogens, Risk Factors and Quality of Life in an Observational Study of Native vs. Prosthetic Aortic Valve Endocarditis Surgery.
- Author
-
Heller A, Zerdzitzki M, Hegner P, Song Z, Schach C, Hitzenbichler F, Kozakov K, Thiedemann C, Provaznik Z, Schmid C, and Li J
- Abstract
Background: Native (NVE) and prosthetic (PVE) aortic valve endocarditis (AVE) remain a surgical challenge with an ongoing trend towards more complex surgical procedures. Methods: First-time NVE was compared with PVE, focusing on pathogens, risk factors, perioperative course, postoperative follow-up, including recurrent infection, as well as health-related quality of life (HRQOL). Results: From 2007 to 2022, surgical intervention for AVE was necessary in 231 patients with 233 episodes of infective aortic valve endocarditis, i.e., there were only two cases of reinfection (NVE group). The study group consisted of 130 cases with NVE and 103 with PVE. Overall, a median of 40.3% of survivors were in NYHA class I or II. In-hospital mortality was higher in the PVE group with 13.3%. The most common pathogen was Staphylococcus aureus , with 24.9% across both groups. EuroSCORE II was higher in the PVE group (19.0 ± 14.3% total, NVE 11.1 ± 8.1%, PVE 27.8 ± 14.6%; p < 0.05), reflecting an older, more co-morbid patient cohort. Abscess formation was also more common in the PVE group, while vegetations were more common in the NVE group. The 5-year and 10-year survival rates did not differ significantly between NVE and PVE and were 74.4% and 52.2% for the NVE group, respectively, and 67.4% and 52.9% for the PVE group, respectively. The HRQOL as assessed by the Minnesota Living with HF Questionnaire (MLHFQ) demonstrated no significant difference between both groups. Conclusions: Long-term survival and QoL after surgical treatment of infective aortic valve endocarditis are excellent and do not depend on the type of replacement.
- Published
- 2024
- Full Text
- View/download PDF
17. Negative impact of face masks in patients with interstitial lung disease: A prospective study.
- Author
-
Mohr A, Zahn S, Geismann F, Blaas S, Pfeifer M, Malfertheiner M, Salzberger B, Hanses F, Bauernfeind S, Koch M, and Hitzenbichler F
- Abstract
Introduction: Face masks increase airway resistance, data on the actual extent of this effect are scarce. The aim of this study was to assess the effect of different mask types on clinical parameters during moderate exercise in healthy non-smokers, active smokers and patients with interstitial lung disease (ILD) without the need of oxygen therapy., Methods: In a prospective observational pilot study participants performed a six-minute walk test without mask, with a surgical mask, a well-fitted FFP2 mask and with a valved FFP3 mask. Respiratory rate, blood pressure, heart rate, blood gas analysis parameters, dyspnoea and six-minute walk distance were measured. Data were analysed in an ANOVA model., Results: 21 healthy participants, 17 active smokers without known pulmonary disease and 15 patients with interstitial lung disease were included. Participants with ILD had a significant lower walking distance, a higher respiratory rate and a lower pO
2 when using FFP2 masks, but not with valved FFP3 masks or surgical masks compared to not wearing a mask., Conclusion: For patients with ILD without the need of oxygen therapy wearing an FFP2 mask had a negative impact on pO2 , respiratory rate and walking distance in the six-minute walk test. This effect was not seen with valved FFP3 masks or surgical masks., Competing Interests: MP: president (2019–2021) and board member (2017–2023) of German Society of Respiratory Medicine. The other authors declare that they have no conflicht of interest., (Thieme. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
18. Case report: Local bacteriophage therapy for fracture-related infection with polymicrobial multi-resistant bacteria: hydrogel application and postoperative phage analysis through metagenomic sequencing.
- Author
-
Alt V, Gessner A, Merabishvili M, Hitzenbichler F, Mannala GK, Peterhoff D, Walter N, Pirnay JP, Hiergeist A, and Rupp M
- Abstract
Fracture-related infections can be challenging, particularly with concomitant severe bone defects and multi-resistant microorganisms. We present a case of a 42-year-old patient with a fracture-related infection following a war injury from a gunshot, resulting in a 12-cm subtrochanteric segmental bone defect and the detection of four different multi-resistant Gram-negative bacteria. Due to antibiotic drug resistance, treatment with bacteriophages was considered. Phage susceptibility testing revealed the activity of a commercially available bacteriophage cocktail (Intesti bacteriophage, Eliava Institute, Tbilisi, Georgia). This phage cocktail was included in a modified two-stage Masquelet technique. During the first intervention, the bone was debrided and samples for microbiological and phage testing were harvested. The indwelling intramedullary rod was removed, and the bone defect was filled with a PMMA spacer loaded with colistin and the bone stabilized with a plate. During the second procedure, the PMMA spacer was removed and a silver-coated angular stable plate was implanted. The bone defect was filled with a fibular autograft and allograft cancellous bone chips. At the end of the procedure, the Intesti bacteriophage cocktail was injected into a DAC hydrogel and this bacteriophage hydrogel composite was then put onto the angular stable plate. Postoperatively the wound fluid was collected over 72 h, and high-throughput metagenomic sequencing was performed. This showed a time-dependent release of the bacteriophages in the wound fluid, with a relatively high concentration after 12 h, decreasing to DNA copies of 0 after 72 h. Furthermore, we have assessed the release of phages from DAC gel and the effect of DAC gel on the phages in vitro . The results showed a stable and rapid release of phages from the DAC gel (~1×10
3 PFU/mL). The clinical course of the patient showed no relapse of the infection with good bone consolidation of the bone defect after 1 year without the need for any surgical revision. To the best of our knowledge, this is the first case that shows the detection of bacteriophage DNA copies by high-throughput metagenomics sequencing in a patient with a complex fracture-related infection. Successful treatment of this case encourages further investigation of bacteriophage therapy in patients with complex bone and joint infections., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Alt, Gessner, Merabishvili, Hitzenbichler, Mannala, Peterhoff, Walter, Pirnay, Hiergeist and Rupp.)- Published
- 2024
- Full Text
- View/download PDF
19. Impact of Selective Reporting of Antibiotic Susceptibility Test Results on Antibiotic Use in Patients with Bloodstream Infection with Streptococcus pneumoniae .
- Author
-
Geismann F, Brueckner K, Pfeifer M, Salzberger B, Bauernfeind S, Hitzenbichler F, Simon M, Caplunik-Pratsch A, Schneider-Brachert W, Wiest C, Hinterberger T, Ruegamer T, and Mohr A
- Abstract
Introduction: Invasive pneumococcal disease is a major cause of morbidity and mortality in infectious diseases. Selective reporting of antibiotic susceptibility test results might lead to a tailored antibiotic therapy and could therefore be an important antibiotic stewardship program intervention. The aim of this study was to analyse whether a switch to selective reporting of antibiotic test results leads to a more focused antibiotic therapy in patients with a bloodstream infection with Streptococcus pneumoniae ., Methods: This study was performed as a retrospective cohort study at the University Hospital Regensburg, Germany. All blood cultures positive for Streptococcus pneumoniae between 2006 and 2021 were analysed. In 2014, a switch to selective reporting of antibiotic susceptibility test results omitting sensitivity results for agents not recommended was introduced., Results: Twenty-four hours after final antibiotic susceptibility test results were available, 20.9% before (BI) versus 15.4% after implementation (AI) of selective reporting of antibiotic test results received a narrow-spectrum penicillin, while only 2.3% BI versus 5.8% AI received a narrow-spectrum penicillin from the beginning., Conclusion: Selective reporting of antibiotic susceptibility test results without further antimicrobial stewardship interventions did not lead to a higher use of a narrow-spectrum penicillin in this study., Competing Interests: Arno Mohr received travel grants from Gilead. Bernd Salzberger received a consulting honorarium from Roche AG. All other authors declare they have no financial interests., (© 2024 The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
20. Complexity of patients with or without infectious disease consultation in tertiary-care hospitals in Germany.
- Author
-
Meyer-Schwickerath C, Weber C, Hornuss D, Rieg S, Hitzenbichler F, Hagel S, Ankert J, Hennigs A, Glossmann J, and Jung N
- Subjects
- Humans, Tertiary Care Centers, Retrospective Studies, Referral and Consultation, Germany epidemiology, Communicable Diseases diagnosis, Communicable Diseases epidemiology, Communicable Diseases therapy
- Abstract
Purpose: Patients seen by infectious disease (ID) specialists are more complex compared to patients treated by other subspecialities according to Tonelli et al. (2018). However, larger studies on the complexity of patients related to the involvement of ID consultation services are missing., Methods: Data of patients being treated in 2015 and 2019 in four different German university hospitals was retrospectively collected. Data were collected from the hospitals' software system and included whether the patients received an ID consultation as well as patient clinical complexity level (PCCL), case mix index (CMI) and length of stay (LOS) as a measurement for the patients' complexity. Furthermore, a comparison of patients with distinct infectious diseases treated with or without an ID consultation was initiated., Results: In total, 215.915 patients were included in the study, 3% (n = 6311) of those were seen by an ID consultant. Patients receiving ID consultations had a significantly (p < 0.05) higher PCCL (median 4 vs. 0), CMI (median 3,8 vs. 1,1) and deviation of the expected mean LOS (median 7 days vs. 0 days) than patients in the control group. No differences among hospitals or between years were observed. Comparing patients with distinct infectious diseases treated with or without an ID consultation, the differences were confirmed throughout the groups., Conclusion: Patients receiving ID consultations are highly complex, frequently need further treatment after discharge and have a high economic impact. Thus, ID specialists should be clinically trained in a broad spectrum of diseases and treating these complex patients should be sufficiently remunerated., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
21. Postpartum cryptococcosis in an HIV-negative patient.
- Author
-
Gottschling M, Blaas S, Geismann F, Lerzer C, Malfertheiner M, Salzberger B, Hitzenbichler F, Scharf S, Weber F, and Mohr A
- Subjects
- Pregnancy, Female, Humans, Postpartum Period, Antifungal Agents therapeutic use, Cryptococcus neoformans, Cryptococcosis diagnosis, Cryptococcosis drug therapy, HIV Infections drug therapy, Amphotericin B
- Abstract
Purpose and Methods: We present an unusual case of an HIV-negative patient with postpartum pulmonary cryptococcosis and cryptococcemia., Results: The diagnostic methods and treatment of cryptococcosis in a postpartum patient are presented in this case report. Due to anaphylaxis to liposomal amphotericin B, desensitisation to the drug was performed., Conclusion: We would like to raise awareness about rare infections such as cryptococcosis in pregnancy and the postpartum period. In addition, we were able to document a successful desensitisation to liposomal amphotericin B., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.)
- Published
- 2024
- Full Text
- View/download PDF
22. Refractory circulatory failure in COVID-19 patients treated with veno-arterial ECMO a retrospective single-center experience.
- Author
-
Wiest C, Philipp A, Foltan M, Geismann F, Schneckenpointer R, Baumgartner S, Sticht F, Hitzenbichler F, Arzt M, Fisser C, Stadlbauer A, Dienemann T, Maier LS, Lunz D, Mueller T, and Lubnow M
- Subjects
- Humans, Middle Aged, Retrospective Studies, Extracorporeal Membrane Oxygenation adverse effects, COVID-19 complications, COVID-19 therapy, Heart Failure complications, Heart Failure therapy, Heart Failure diagnosis, Shock etiology
- Abstract
Objective: In this retrospective case series, survival rates in different indications for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and differential diagnoses of COVID-19 associated refractory circulatory failure are investigated., Methods: Retrospective analysis of 28 consecutive COVID-19 patients requiring VA-ECMO. All VA-ECMO's were cannulated peripherally, using a femoro-femoral cannulation., Results: At VA-ECMO initiation, median age was 57 years (IQR: 51-62), SOFA score 16 (IQR: 13-17) and norepinephrine dosing 0.53μg/kg/min (IQR: 0.35-0.87). Virus-variants were: 61% wild-type, 14% Alpha, 18% Delta and 7% Omicron. Indications for VA-ECMO support were pulmonary embolism (PE) (n = 5, survival 80%), right heart failure due to secondary pulmonary hypertension (n = 5, survival 20%), cardiac arrest (n = 4, survival 25%), acute heart failure (AHF) (n = 10, survival 40%) and refractory vasoplegia (n = 4, survival 0%). Among the patients with AHF, 4 patients suffered from COVID-19 associated heart failure (CovHF) (survival 100%) and 6 patients from sepsis associated heart failure (SHF) (survival 0%). Main Complications were acute kidney injury (AKI) 93%, renal replacement therapy was needed in 79%, intracranial hemorrhage occurred in 18%. Overall survival to hospital discharge was 39%., Conclusion: Survival on VA-ECMO in COVID-19 depends on VA-ECMO indication, which should be considered in further studies and clinical decision making. A subgroup of patients suffers from acute heart failure due to inflammation, which has to be differentiated into septic or COVID-19 associated. Novel biomarkers are required to ensure reliable differentiation between these entities; a candidate might be soluble interleukin 2 receptor., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Wiest et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
23. SARS-CoV2 evokes structural brain changes resulting in declined executive function.
- Author
-
Deuter D, Hense K, Kunkel K, Vollmayr J, Schachinger S, Wendl C, Schicho A, Fellner C, Salzberger B, Hitzenbichler F, Zeller J, Vielsmeier V, Dodoo-Schittko F, Schmidt NO, and Rosengarth K
- Subjects
- Humans, Executive Function physiology, RNA, Viral, SARS-CoV-2, Brain, Magnetic Resonance Imaging methods, Gray Matter, COVID-19, White Matter
- Abstract
Background: Several research has underlined the multi-system character of COVID-19. Though effects on the Central Nervous System are mainly discussed as disease-specific affections due to the virus' neurotropism, no comprehensive disease model of COVID-19 exists on a neurofunctional base by now. We aimed to investigate neuroplastic grey- and white matter changes related to COVID-19 and to link these changes to neurocognitive testings leading towards a multi-dimensional disease model., Methods: Groups of acutely ill COVID-19 patients (n = 16), recovered COVID-19 patients (n = 21) and healthy controls (n = 13) were prospectively included into this study. MR-imaging included T1-weighted sequences for analysis of grey matter using voxel-based morphometry and diffusion-weighted sequences to investigate white matter tracts using probabilistic tractography. Comprehensive neurocognitive testing for verbal and non-verbal domains was performed., Results: Alterations strongly focused on grey matter of the frontal-basal ganglia-thalamus network and temporal areas, as well as fiber tracts connecting these areas. In acute COVID-19 patients, a decline of grey matter volume was found with an accompanying diminution of white matter tracts. A decline in executive function and especially verbal fluency was found in acute patients, partially persisting in recovered., Conclusion: Changes in gray matter volume and white matter tracts included mainly areas involved in networks of executive control and language. Deeper understanding of these alterations is necessary especially with respect to long-term impairments, often referred to as 'Post-COVID'., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Deuter et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
24. Infection image: reoccurrence of Kaposi`s sarcoma after SARS-CoV-2 mRNA vaccination in an HIV-infected patient.
- Author
-
Hitzenbichler F, Weber M, and Salzberger B
- Subjects
- Humans, SARS-CoV-2 genetics, Vaccination, RNA, Messenger, Antibodies, Viral, COVID-19 prevention & control, Sarcoma, Kaposi diagnosis, HIV Infections complications
- Published
- 2024
- Full Text
- View/download PDF
25. Fracture-Related Infection-Epidemiology, Etiology, Diagnosis, Prevention, and Treatment.
- Author
-
Rupp M, Walter N, Bärtl S, Heyd R, Hitzenbichler F, and Alt V
- Subjects
- Humans, Retrospective Studies, Anti-Bacterial Agents therapeutic use, Causality, Fractures, Bone surgery, Staphylococcal Infections
- Abstract
Background: Fracture-related infection (FRI) is a challenge to physicians and other workers in health care. In 2018, there were 7253 listed cases of FRI in Germany, corresponding to an incidence of 10.7 cases per 100 000 persons per year., Methods: This review is based on pertinent publications retrieved from a search in PubMed with the search terms "fracture," "infection," "guideline," and "consensus." Aside from the primary literature, international guidelines and consensus recommendations were evaluated as well., Results: FRI arise mainly from bacterial contamination of the fracture site. Staphylococcus aureus is the most commonly detected pathogen. The treatment is based on surgery and antibiotics and should be agreed upon by an interdisciplinary team; it is often difficult because of biofilm formation. Treatment options include implant-preserving procedures and single-stage, two-stage, or multi-stage implant replacement. Treatment failure occurs in 10.3% to 21.4% of cases. The available evidence on the efficacy of various treatment approaches is derived mainly from retrospective cohort studies (level III evidence). Therefore, periprosthetic joint infections and FRI are often discussed together., Conclusion: FRI presents an increasing challenge. Preventive measures should be optimized, and the treatment should always be decided upon by an interdisciplinary team. Only low-level evidence is available to date to guide diagnostic and treatment decisions. High-quality studies are therefore needed to help us meet this challenge more effectively.
- Published
- 2024
- Full Text
- View/download PDF
26. Pathogens and their resistance behavior in necrotizing fasciitis.
- Author
-
Brébant V, Eschenbacher E, Hitzenbichler F, Pemmerl S, Prantl L, and Pawlik M
- Subjects
- Humans, Retrospective Studies, Escherichia coli, Streptococcus pyogenes, Risk Factors, Anti-Bacterial Agents therapeutic use, Fasciitis, Necrotizing diagnosis, Fasciitis, Necrotizing microbiology, Fasciitis, Necrotizing therapy
- Abstract
Background: Necrotizing fasciitis (NF) is a rare but life-threatening condition in which extensive soft tissue destruction can occur very quickly if left untreated. Therefore, timely broad-spectrum antibiotic administration is of prognostic importance in addition to radical surgical debridement., Aim: This study evaluates the cases of NF in our hospital during the last ten years retrospectively with respect to the pathogens involved and their antimicrobial resistance. This approach aims to provide guidance regarding the most targeted initial antibiotic therapy., Methods: We performed a retrospective microbiological study evaluating pathogen detection and resistance patterns including susceptibility testing of 42 patients with NF., Results: Type 1 NF (polymicrobial infection) occurred in 45% of the patients; 31% presented type 2 NF (monomicrobial infection). The most common pathogens detected were E. coli, staphylococci such as Staphylococcus aureus and Staphylococcus epidermidis, Proteus mirabilis, enterococci, and streptococci such as Streptococcus pyogenes. Twelve percent presented an additional fungus infection (type 4). Ten percent showed no cultivation. Two percent (one patient) presented cocci without specification., Conclusion: Most pathogens were sensitive to antibiotics recommended by guidelines. This confirms the targeting accuracy of the guidelines. Further studies are necessary to identify risk factors associated with multidrug resistant infections requiring early vancomycin/meropenem administration.
- Published
- 2024
- Full Text
- View/download PDF
27. 18 F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center.
- Author
-
Sag SJM, Menhart K, Hitzenbichler F, Schmid C, Hofheinz F, van den Hoff J, Maier LS, Hellwig D, Grosse J, and Sag CM
- Subjects
- Humans, Positron Emission Tomography Computed Tomography methods, Fluorodeoxyglucose F18, Retrospective Studies, Abscess diagnostic imaging, Tomography, X-Ray Computed methods, Glycolysis, Radiopharmaceuticals, Endocarditis, Bacterial, Heart Valve Prosthesis, Endocarditis diagnostic imaging
- Abstract
Background: Abnormal activity of
18 F-FDG PET/CT is a major Duke criterion in the diagnostic work-up of infective prosthetic valve endocarditis (IE). We hypothesized that quantitative lesion assessment by18 F-FDG PET/CT-derived standard maximum uptake ratio (SURmax), metabolic volume (MV), and total lesion glycolysis (TLG) might be useful in distinct subgroups of IE patients (e.g. IE-related abscess formation)., Methods: All patients (n = 27) hospitalized in our tertiary IE referral medical center from January 2014 to October 2018 with preoperatively performed18 F-FDG PET/CT and surgically confirmed IE were included into this retrospective analysis., Results: Patients with surgically confirmed abscess formation (n = 10) had significantly increased MV (by ~ fivefold) and TLG (by ~ sevenfold) as compared to patients without abscess (n = 17). Receiver operation characteristics (ROC) analyses demonstrated that TLG (calculated as MV × SURmean, i.e. TLG (SUR)) had the most favorable area under the ROC curve (0.841 [CI 0.659 to 1.000]) in predicting IE-related abscess formation. This resulted in a sensitivity of 80% and a specificity of 88% at a cut-off value of 14.14 mL for TLG (SUR)., Conclusion: We suggest that18 F-FDG PET/CT-derived quantitative assessment of TLG (SUR) may provide a novel diagnostic tool in predicting endocarditis-associated abscess formation., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
28. Antibiotic Prophylaxis and Empirical Antibiotic Therapy in Primary Arthroplasty and Periprosthetic Joint Infections: Current Practice and Need for Therapy Optimization.
- Author
-
Rupp M, Walter N, Baertl S, Lang S, Herbst T, Hitzenbichler F, and Alt V
- Subjects
- Humans, Antibiotic Prophylaxis methods, Retrospective Studies, Anti-Bacterial Agents therapeutic use, Cephalosporins therapeutic use, Arthroplasty, Replacement, Knee adverse effects, Arthroplasty, Replacement, Hip adverse effects, Arthritis, Infectious surgery, Prosthesis-Related Infections drug therapy, Prosthesis-Related Infections prevention & control, Prosthesis-Related Infections etiology
- Abstract
The aim of the present work was to survey the situation of healthcare regarding the use of prophylactic and empirical antibiotics in primary arthroplasty and treatment of periprosthetic joint infections (PJI). For this purpose, a survey was conducted at German university and occupational accident hospitals. Survey data was compared to previously published data on the antimicrobial regimes of PJI (n=81) patients (n=81) treated in our department between 2017 and 2020. A homogeneous picture emerged for the prophylactic administration of antibiotics in the context of primary arthroplasty. In 93.2% (elective) and 88.6% (fracture treatment) of the hospitals, first or second generation cephalosporins were administered perioperatively for infection prophylaxis in primary hip arthroplasty. The empirical antibiotic treatment of PJIs showed a clearly inhomogeneous therapeutic picture. Monotherapy with an aminopenicillin plus a beta-lactamase inhibitor is used most frequently (38.7%); first and second generation cephalosporins are used second most frequently as monotherapy (18.2%). In light of the global problem of antibiotic multi-resistance, clinical use of antibiotics has to be reasonable and effective. The present results highlight the further need to improve awareness and following existing guidelines in the administration of empirical antibiotic therapy in PJI., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
29. [Rare cause of necrotizing pneumonia : A case report].
- Author
-
Gottschling M, Lerzer C, Geismann F, Schmalenberger D, Blaas S, Simsek M, Malfertheiner M, Salzberger B, Hitzenbichler F, Hamer OW, Utpatel K, Neu R, Ried M, and Mohr A
- Subjects
- Humans, Adult, Lung pathology, Pneumonia, Necrotizing diagnosis, Amebiasis pathology, Pneumonia diagnosis, Lung Abscess diagnosis
- Abstract
A 29-year-old Indian patient was admitted to the authors' pulmonary clinic with cough and fever. Community-acquired pneumonia was initially suspected. Various antibiotic therapies were administered, which did not lead to any clinical improvement. Despite detailed diagnostics, no pathogen was found. Computed tomography showed rapidly progressive pneumonia in the left upper lobe. Since the infection could not be managed conservatively, upper lobe resection was performed. Histologically, an amoebic abscess was found to be the cause of the infection. Since cerebral and hepatic abscesses were also found, hematogenous dissemination may be assumed., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
30. Short report: impact of selective reporting of antibiotic susceptibility testing on antibiotic use in patients with bloodstream infection with Enterococcus faecalis.
- Author
-
Geismann F, Handschuh S, Malfertheiner M, Salzberger B, Bauernfeind S, Hitzenbichler F, Simon M, Caplunik-Pratsch A, Schneider-Brachert W, Wiest C, Ruegamer T, and Mohr A
- Subjects
- Humans, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Enterococcus faecalis, Retrospective Studies, Microbial Sensitivity Tests, Ampicillin, Enterococcus faecium, Sepsis, Gram-Positive Bacterial Infections diagnosis, Gram-Positive Bacterial Infections drug therapy
- Abstract
Introduction: Bloodstream infections with Enterococcus faecalis are associated with relevant morbidity and mortality. Targeted antimicrobial therapy is essential. The choice of an adequate treatment may be challenging when susceptibility testing offers different options. Selective reporting of antibiotic susceptibility test results might lead to a more tailored antibiotic therapy and could therefore be an important antimicrobial stewardship program intervention. The aim of this study was to analyse whether the introduction of selective reporting of antibiotic test results leads to a more targeted antibiotic therapy in patients with bloodstream infection with Enterococcus faecalis., Methods: This study was performed as a retrospective cohort study at the University Hospital Regensburg, Germany. All patients with blood cultures positive for Enterococcus faecalis between March 2003 and March 2022 were analysed. In February 2014 selective reporting of antibiotic susceptibility test results omitting sensitivity results for agents not recommended was introduced., Results: 263 patients with blood cultures positive for Enterococcus faecalis were included. After introduction of selective reporting of antibiotic tests (AI) significantly more patients received ampicillin than before introduction of selective reporting (BI) (9.6% BI vs. 34.6% AI, p < 0.001)., Conclusion: Selective reporting of antibiotic susceptibility test results led to a significantly higher use of ampicillin., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.)
- Published
- 2023
- Full Text
- View/download PDF
31. [Antibiotic use for prophylaxis and empirical therapy of fracture-related infections in Germany : A survey of 44 hospitals].
- Author
-
Bärtl S, Walter N, Lang S, Hitzenbichler F, Rupp M, and Alt V
- Subjects
- Humans, Vancomycin, Meropenem, Penicillins therapeutic use, Cephalosporins therapeutic use, Fracture Fixation, Internal, Hospitals, Surveys and Questionnaires, Anti-Bacterial Agents therapeutic use, Fractures, Open drug therapy
- Abstract
Background: Antibiotics play an important role in the prophylaxis and treatment of infections in orthopedic trauma surgery; however, there seems to be remarkable differences in the clinical antibiotic practice between hospitals, particularly for open fractures and for the empirical therapy of fracture-related infections (FRI)., Methods: Therefore, we intended to evaluate the current clinical praxis in university and workers' compensation hospitals in Germany with a questionnaire on prophylaxis and empirical treatment of FRI. The results were compared with the resistance profile of 86 FRI patients in order to analyze the hypothetical effectiveness of the empirical treatment., Results: A total of 44 hospitals (62.0%) responded. A homogeneous antibiotic prophylaxis (95.5% of all hospitals) with cephalosporins was reported for perioperative prophylaxis of internal fixation of closed fractures. For open fractures, eight different monotherapy and combination treatment concepts were reported. In empirical treatment of FRI, 12 different therapeutic concepts were reported, including aminopenicillins/beta lactamase inhibitors (BLI) (31.8%), cephalosporins (31.8%), and ampicillin/sulbactam + vancomycin (9.1%). In terms of the hypothetical effectiveness of these antibiotic regimes, low sensitivity rates of 65.1% and 74.4% for cephalosporins and aminopenicillins/BLI, respectively, were found. For the combination vancomycin + meropenem, the highest hypothetical sensitivity (91.9%) was detected., Discussion: Based on the existing, institution-specific pathogen spectrum, the combination therapy including meropenem and vancomycin seems to be of value but should be restricted to patients with multiple revision procedures or a septic course of infection in order to prevent the selection of highly resistant pathogens., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
32. Short-course versus long-course antibiotic treatment for uncomplicated vancomycin-resistant enterococcal bacteraemia: a retrospective multicentre cohort study.
- Author
-
Bahrs C, Rieg S, Hennigs A, Hitzenbichler F, Brehm TT, Rose N, Jacobi RJ, Heine V, Hornuss D, Huppertz G, Hagel S, and Hanses F
- Subjects
- Adult, Humans, Vancomycin therapeutic use, Retrospective Studies, Cohort Studies, Anti-Bacterial Agents, Bacteremia microbiology, Vancomycin-Resistant Enterococci, Gram-Positive Bacterial Infections drug therapy, Gram-Positive Bacterial Infections microbiology
- Abstract
Objectives: The optimal treatment duration for vancomycin-resistant enterococcal (VRE) bacteraemia is still a matter of debate. The aim of the present study was to compare short-course (≤9 days) and long-course (≥10 days) antibiotic treatments in hospitalized adult patients with uncomplicated VRE bacteraemia., Methods: This retrospective study was conducted in four university hospitals in Germany. Adult patients with a positive blood culture for a VRE were screened from 1 January 2016 to 31 December 2018. Only patients who received a VRE-active antibiotic for at least 48 hours were included. The exclusion criteria were a survival of <10 days and a deep-seated source of infection requiring prolonged treatment. To compare the outcome of short-course therapy with that of long-course therapy, 30-day and 90-day overall mortality, relapse within 90 days, duration of hospitalization, and potential antibiotic-related adverse events were analysed by inverse probability of treatment weighting using the propensity score and by additional covariate adjustment., Results: Of the 363 patients screened, 219 (60.3%) patients were included in the final analysis. Among them, 48 (21.9%) patients had underlying haematological diseases. Seventy-eight (35.6%) patients received short-course treatment (median, 7 days; interquartile range, 5-8 days) and 141 (64.4%) patients received long-course treatment (median, 15 days; interquartile range, 12-23.5 days). Thirty-day mortality was similar in both groups (19.2% vs. 22.0%; adjusted OR, 1.15; p 0.773). Duration of hospitalization (in total and after onset of bacteraemia) was significantly shorter (p < 0.05) in the short-course treatment group, whereas other secondary outcome parameters did not differ between both groups., Discussion: Our study suggests that short-course treatment might not be associated with a worse outcome in patients with uncomplicated VRE bacteraemia., (Copyright © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
33. The Long-Term Support of COVID-19 Patients With Veno-Venous Extracorporeal Membrane Oxygenation.
- Author
-
Wiest C, Philipp A, Lunz D, Steinmann JF, Eissnert C, Kees M, Kieninger M, Dienemann T, Ritzka M, Schweinger S, Pross A, Fisser C, Malfertheiner MV, Schneckenpointner R, Lange TJ, Schulz C, Geismann F, Foltan M, Schettler F, Salzberger B, Hitzenbichler F, Hanses F, Schmidt B, Arzt M, Sinner B, Graf B, Maier LS, Müller T, and Lubnow M
- Subjects
- Humans, Extracorporeal Membrane Oxygenation, COVID-19, Respiratory Insufficiency therapy
- Published
- 2023
- Full Text
- View/download PDF
34. Multidisciplinary Treatment of Fracture-Related Infection Has a Positive Impact on Clinical Outcome-A Retrospective Case Control Study at a Tertiary Referral Center.
- Author
-
Rupp M, Walter N, Popp D, Hitzenbichler F, Heyd R, Geis S, Kandulski M, Thurn S, Betz T, Brochhausen C, and Alt V
- Abstract
Objectives: Fracture-related infection (FRI) is a major complication in orthopedic and trauma surgery. The management and choice of treatment can be difficult depending on multiple factors. Therefore, we implemented a weekly multidisciplinary team discussion to determine diagnostic and treatment strategies in FRI patients and aimed to analyze its effect on clinical outcomes., Methods: Clinical outcomes of FRI patients treated before and after implementation of a structured multidisciplinary treatment (MDT) approach with a weekly case discussion were compared at a follow-up of 12 months., Results: In total, n = 117 were eligible for enrolment, whereby n = 58 patients (72.4% male, mean age 56.7 ± 16.8 years) constituted the MDT group and n = 59 patients (72.9% male, mean age 55.0 ± 16.5 years) the control group. In the MDT group more cases were treated with local antibiotics (67.2% vs. 27.1%, p < 0.001) and significant less amputations (3.4% vs. 6.8%, p = 0.014), as well as less revision surgeries (1.5 ± 1.2 (0-5) vs. 2.2 ± 1.2 (0-7), p = 0.048) were performed. A trend towards less debridement, antibiotics and implant retention (DAIR) procedures, lower rates of recurrence of infection and less treatment failures in the MDT group was observable, even though not statistically significant., Conclusion: An MDT approach providing a patient tailored treatment concept in the treatment of FRI patients appears to be beneficial for the affected patients. Quality and efficacy of implemented MDT meetings should further be evaluated to provide sufficient evidence to further implement this valuable tool in clinical practice and decision making.
- Published
- 2023
- Full Text
- View/download PDF
35. Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination.
- Author
-
Bauernfeind S, Einhauser S, Tydykov L, Mader AL, Salzberger B, Hitzenbichler F, Mohr A, Burkhardt R, Wagner R, and Peterhoff D
- Abstract
In a previous study, we described a highly significant association between reactogenicity and SARS-CoV-2 RBD IgG titers and wild-type neutralization capacity in males after basic vaccination with BNT162b2. The objective of this study was to assess whether this benefit was long lasting and also evident after BNT162b2 booster vaccination. Reactogenicity was classified into three groups: no or minor injection site symptoms, moderate (not further classified) and severe adverse reactions (defined as any symptom(s) resulting in sick leave). We initially compared 76 non-immunocompromised individuals who reported either no or minor injection site symptoms or severe adverse reactions after second vaccination. In total, 65 of them took part in another blood sampling and 47 were evaluated after booster vaccination. 26 weeks after second vaccination, men who reported severe adverse reactions after second vaccination had 1.7-fold higher SARS-CoV-2 RBD IgG titers ( p = 0.025) and a 2.5-fold better neutralization capacity ( p = 0.006) than men with no or only minor injection site symptoms. Again, no association was found in women. Reactogenicity of BNT162b2 booster vaccination was different from second vaccination according to our classification and was no longer associated with SARS-CoV-2 RBD IgG titers or wild-type neutralization capacity. To conclude, after BNT162b2 basic vaccination, the association between reactogenicity and humoral immune response in men persisted over time but was no longer detectable after BNT162b2 booster vaccination.
- Published
- 2022
- Full Text
- View/download PDF
36. [Current practice of empiric antibiotic treatment for spondylodiscitis].
- Author
-
Lang S, Walter N, Neumann C, Bärtl S, Simon M, Ehrenschwender M, Hitzenbichler F, Alt V, and Rupp M
- Subjects
- Ampicillin, Humans, Microbial Sensitivity Tests, Sulbactam, Vancomycin, Anti-Bacterial Agents therapeutic use, Discitis drug therapy
- Abstract
Background and Research Question: In pyogenic spondylodiscitis, infections with coagulase-negative staphylococci must be given increasing importance. Empirical antibiosis is particularly necessary in patients with severe or progressive neurological deficits or hemodynamic instability, as well as in the case of culture-negative spondylodiscitis. It is unclear whether uniform empirical antibiosis standards adapted to the resistance profiles exist in Germany., Study Design and Methods: A survey on the empirical antibiotic therapy for pyogenic spondylodiscitis was conducted at German university and Berufsgenossenschaft clinics, each in the departments of orthopedics and trauma surgery. The survey results were applied to the resistance profiles of pathogens in 45 spondylodiscitis patients treated in our department between 2013 and 2020. Thus, the potential susceptibility and resistance rates were calculated for the indicated antibiotic therapies., Results: Of the 71 clinics queried, a total of 44 (62.0%) responded. Sixteen different antibiotic therapies were reported as standard regimes. Among these, 14 different combination therapies were reported. The most commonly reported empirical antibiotics, namely amoxicillin/clavulanic acid or ampicillin/sulbactam (29.5%) and cephalosporins (18.2%) showed high potential resistance rates of 20.0% and 35.6%, respectively, in relation to the previously published resistance profile. The highest potential susceptibility rates were achieved with a combination of vancomycin + ampicillin/sulbactam (91.1% sensitive pathogens), vancomycin + piperacillin/tazobactam (91.1% sensitive pathogens), and ampicillin/sulbactam + teicoplanin (95.6% sensitive pathogens). One out of these combinations was reported as standard regime by three clinics (6.8%)., Conclusion: The nationwide survey of empiric antibiotic treatment for pyogenic spondylodiscitis revealed a large heterogeneity in the standard of care. A combination of a broad-spectrum-β-lactam antibiotic with an additional glycopeptide antibiotic may be justified., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
37. Diagnostic value of FDG PET/CT imaging in patients with surgically managed infective endocarditis: results of a retrospective analysis at a tertiary center.
- Author
-
Sag SJM, Menhart K, Grosse J, Hitzenbichler F, Hanses F, Mohr A, Salzberger B, Zerdzitzki M, Hilker M, Rupprecht L, Hellwig D, Schmid C, Maier LS, and Sag CM
- Subjects
- Fluorodeoxyglucose F18, Humans, Positron Emission Tomography Computed Tomography methods, Radiopharmaceuticals, Retrospective Studies, Endocarditis diagnostic imaging, Endocarditis surgery, Endocarditis, Bacterial diagnosis, Heart Valve Prosthesis
- Abstract
Background: We assessed the diagnostic value of FDG PET/CT in a real-world cohort of patients with surgically managed infective endocarditis (IE)., Methods: We performed a retrospective analysis of all patients hospitalized in a tertiary IE referral medical center from January 2014 to October 2018 fulfilling the following criteria: ICD-10 code for IE and OPS code for both, heart surgery and FDG PET/CT., Results: Final analysis included 29 patients, whereof 28 patients had surgically proven IE. FDG PET/CT scan was true-positive in 15 patients (sensitivity (SEN) 56%) and false-negative in 12 patients. Combination of Duke criteria (DC) with FDG PET/CT scan resulted in gain of SEN for all patients with confirmed IE (SEN of DC 79% vs SEN of combination DC and FDG PET/CT 89%), driven by a relevant gain in PVE patients only (SEN of DC 78% vs SEN of combination DC and FDG PET/CT 94%). Interestingly, higher prosthesis age was observed in patients with false-negative scans., Conclusions: We found a SEN of 56% for FDG PET/CT in a real-world cohort of patients with surgically proven IE which was associated with a 16% gain of IE diagnosis in patients with PVE when combined with DC., (© 2020. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
38. Health Care Workers' Sick Leave due to COVID-19 Vaccination in Context With SARS-CoV-2 Infection and Quarantine-A Multicenter Cross-Sectional Survey.
- Author
-
Bauernfeind S, Huppertz G, Mueller K, Hitzenbichler F, Hardmann L, Pemmerl S, Hollnberger H, Sieber W, Wettstein M, Seeliger S, Kienle K, Paetzel C, Kutz N, Daller D, Zorger N, Mohr A, Lampl BMJ, and Salzberger B
- Abstract
Background: Reactogenicity of coronavirus disease 2019 (COVID-19) vaccines can result in inability to work. The object of this study was to evaluate health care workers' sick leave after COVID-19 vaccination and to compare it with sick leave due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and quarantine leave., Methods: A multicenter cross-sectional survey was conducted at Regensburg University Medical Center and 10 teaching hospitals in South-East Germany from July 28 to October 15, 2021., Results: Of 2662 participants, 2309 (91.8%) were fully vaccinated without a history of SARS-CoV-2 infection. Sick leave after first/second vaccination occurred in 239 (10.4%) and 539 (23.3%) participants. In multivariable logistic regression, the adjusted odds ratio for sick leave after first/second vaccination compared with BNT162b2 was 2.26/3.72 for mRNA-1237 (95% CI, 1.28-4.01/1.99-6.96) and 27.82/0.48 for ChAdOx1-S (95% CI, 19.12-40.48/0.24-0.96). The actual median sick leave (interquartile range [IQR]) was 1 (0-2) day after any vaccination. Two hundred fifty-one participants (9.4%) reported a history of SARS-CoV-2 infection (median sick leave [IQR] 14 [10-21] days), 353 (13.3%) were quarantined at least once (median quarantine leave [IQR], 14 [10-14] days). Sick leave due to SARS-CoV-2 infection (4642 days) and quarantine leave (4710 days) accounted for 7.7 times more loss of workforce than actual sick leave after first and second vaccination (1216 days) in all fully vaccinated participants., Conclusions: Sick leave after COVID-19 vaccination is frequent and is associated with the vaccine applied. COVID-19 vaccination should reduce the much higher proportion of loss of workforce due to SARS-CoV-2 infection and quarantine., (© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2022
- Full Text
- View/download PDF
39. What Is the Most Effective Empirical Antibiotic Treatment for Early, Delayed, and Late Fracture-Related Infections?
- Author
-
Baertl S, Walter N, Engelstaedter U, Ehrenschwender M, Hitzenbichler F, Alt V, and Rupp M
- Abstract
Antibiotic treatment strategies for fracture-related infections (FRI) are often extrapolated from periprosthetic joint infections (PJI), although, in contrast to PJI, detailed analysis of pathogens and their antibiotic resistance is missing. Therefore, this study aimed to investigate antibiotic susceptibility profiles to identify effective empiric antibiotic treatment for early-, delayed-, and late-onset FRI. Patients treated for FRI from 2013 to 2020 were grouped into early (<2 weeks), delayed (3−10 weeks), and late (>10 weeks) onset of infection. Antibiotic susceptibility profiles were examined with respect to broadly used antibiotics and antibiotic combinations. In total, 117 patients (early n = 19, delayed n = 60, late n = 38) were enrolled. In early-onset FRI, 100.0% efficacy would be achieved by meropenem + vancomycin, gentamicin + vancomycin, co-amoxiclav + glycopeptide, ciprofloxacin + glycopeptide and piperacillin/tazobactam + glycopeptide. For patients with delayed FRI, the highest susceptibility was revealed for meropenem + vancomycin, gentamicin + vancomycin and ciprofloxacin + glycopeptide (96.7%). Meropenem + vancomycin was the most effective empiric antimicrobial in patients with late-onset of infection with 92.1% coverage. No subgroup differences in antibiotic sensitivity profiles were observed except for the combination ciprofloxacin + glycopeptide, which was significantly superior in early FRI (F = 3.304, p = 0.04). Across all subgroups meropenem + vancomycin was the most effective empiric treatment in 95.7% of patients with confirmed susceptibility. Meropenem + vancomycin, gentamicin + vancomycin, co-amoxiclav + glycopeptide are the best therapeutic options for FRI, regardless of the onset of infection. To avoid multidrug resistance, established antibiotic combinations such as co-amoxiclav with a glycopeptide seem to be reasonable as a systemic antibiotic therapy, while vancomycin + gentamicin could be implemented in local antibiotic therapy to reduce adverse events during treatment.
- Published
- 2022
- Full Text
- View/download PDF
40. Low Adherence to Pneumococcal Vaccination in Lung Cancer Patients in a Tertiary Care University Hospital in Southern Germany.
- Author
-
Mohr A, Kloos M, Schulz C, Pfeifer M, Salzberger B, Bauernfeind S, Hitzenbichler F, Plentz A, Loew T, and Koch M
- Abstract
Introduction: The aim of this study was to investigate the adherence to vaccinations, especially pneumococcal vaccinations, in lung cancer patients., Methods: the study was performed at the University Hospital Regensburg, Germany. All patients with a regular appointment scheduled between 1 December 2020 and 29 April 2021 and who provided informed consent were included. Available medical records, vaccination certificates, and a questionnaire were analyzed., Results: we included 136 lung cancer patients (NSCLC n = 113, 83.1%, SCLC n = 23, 16.9%). A correct pneumococcal vaccination according to national recommendations was performed in 9.4% (12/127) of the patients. A correct vaccination was performed for tetanus in 50.4% (66/131), diphtheria in 34.4% (44/128), poliomyelitis in 25.8% (33/128), tick-borne encephalitis in 40.7% (24/59), hepatitis A in 45.5% (7/11), hepatitis B in 38.5% (5/13), shingles in 3.0% (3/101), measles in 50.0% (3/6), pertussis in 47.7% (62/130), influenza in 54.4% (74/136), and meningococcal meningitis in 0% (0/2) of the patients., Conclusion: adherence to pneumococcal vaccinations, as well as to other vaccinations, is low in lung cancer patients.
- Published
- 2022
- Full Text
- View/download PDF
41. Surgical and remote site infections after reconstructive surgery of the head and neck: A risk factor analysis.
- Author
-
Schuderer JG, Spörl S, Spanier G, Gottsauner M, Gessner A, Hitzenbichler F, Meier JK, Reichert TE, and Ettl T
- Subjects
- Antibiotic Prophylaxis, Factor Analysis, Statistical, Humans, Retrospective Studies, Risk Factors, Surgical Wound Infection microbiology, Free Tissue Flaps, Head and Neck Neoplasms complications, Plastic Surgery Procedures adverse effects
- Abstract
The aim of this study was to identify risk factors for surgical (SSI) and remote site (RSI) infections, pathogens and antibiotic resistances in patients after pedicled and free flap reconstruction in the head and neck area. SSI criteria implicated infections affecting superficial or deep tissue in the flap area with purulent discharge, fistula, abscess formation and local infections signs. RSI criteria were defined as infections remote from the surgical site presenting with systemic symptoms like fever, leucocytosis, increase in C-reactive protein, purulent tracheobronchial secretion or deterioration of blood gases. Focus adequate specimen sampling and aerobic and anaerobic incubation and cultivation was performed. Epidemiological data, factors directly related to surgery or reconstruction, perioperative antibiotic regimen, length of stay, autologous blood transfusion and microbiological aspects were retrospectively analysed in 157 patients. 10.8% of patients presented SSI, 12.7% RSI. Cultivated bacteria were sampled from flap sites, blood cultures, central catheters and sputum including mainly gram-negative bacteria (70.3%) being frequently resistant against penicillin (85%) and third generation cephalosporine derivates (48%). Autologous blood transfusion (p = 0.018) and perioperative clindamycin use (p = 0.002) were independent risk factors for overall (SSI and RSI combined) infections. Prior radiation (p = 0.05), autologous blood transfusion (p = 0.034) and perioperative clindamycin use (p = 0.004) were predictors for SSIs. ASA >2 (p = 0.05) was a risk factor for remote site infections and prolonged ICU stay (p = 0.002) was associated with overall infections, especially in irradiated patients. Efforts need to be made in improving patient blood management, antibiotic stewardship and accurate postoperative care to avoid postoperative infections after head and neck reconstructive surgery., Competing Interests: Declaration of competing interest None., (Copyright © 2021 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
42. Periprosthetic joint infection : patients benefit from a multidisciplinary team approach.
- Author
-
Walter N, Rupp M, Baertl S, Ziarko TP, Hitzenbichler F, Geis S, Brochhausen C, and Alt V
- Published
- 2022
- Full Text
- View/download PDF
43. Letter in response to article in journal of infection: "The microbiology of chronic osteomyelitis: Changes over ten years".
- Author
-
Walter N, Baertl S, Engelstaedter U, Ehrenschwender M, Hitzenbichler F, Alt V, and Rupp M
- Subjects
- Anti-Bacterial Agents therapeutic use, Humans, Osteomyelitis drug therapy
- Published
- 2021
- Full Text
- View/download PDF
44. [Cervicofacial actinomycosis].
- Author
-
Brosig AM, Hitzenbichler F, Ernst B, Köstler J, Bohr C, and Künzel J
- Subjects
- Anti-Bacterial Agents therapeutic use, Diagnosis, Differential, Humans, Actinomycosis diagnosis, Actinomycosis drug therapy, Actinomycosis surgery, Actinomycosis, Cervicofacial diagnosis, Actinomycosis, Cervicofacial drug therapy, Actinomycosis, Cervicofacial surgery
- Abstract
Actinomycosis is an infectious disease caused by gram-positive, facultative anaerobic bacteria, which in most cases manifests itself in the cervicofacial area and often has a dentogenic focus. The clinical presentation ranges from acute abscess to chronically fistulating soft tissue processes. Early diagnosis and an appropriate therapeutic approach including a combination of extensive antibiotic treatment and, if necessary, surgical intervention are critical. This article presents five cases of actinomycete infections, which are intended to illustrate the variety of clinical presentations, the problems on the way to the correct diagnosis and possible therapeutic courses., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
45. Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020.
- Author
-
Bauernfeind S, Hitzenbichler F, Huppertz G, Zeman F, Koller M, Schmidt B, Plentz A, Bauswein M, Mohr A, and Salzberger B
- Subjects
- Attitude, Cross-Sectional Studies, Female, Germany, Hospitals, Humans, SARS-CoV-2, Tertiary Healthcare, Vaccination, COVID-19, COVID-19 Vaccines
- Abstract
Coronavirus disease 2019 (Covid-19) vaccination is essential to fight the pandemic. Health care workers (HCWs) are prioritized to get vaccinated, yet uptake of recommended vaccinations is known to be low in this group. In a tertiary care university hospital with a high number of Covid-19 patients in intensive care, 59.5% of surveyed staff (N = 2454) were willing to get vaccinated, 21.4% were unsure and 18.7% refused. Vaccine hesitancy was higher in female, younger and healthy employees without contact to Covid-19 patients; nurses (53.3%) were much less willing to get vaccinated compared to physicians (82.7%)., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
46. Adherence to STIKO recommendations in patients with pulmonary disease in southeast Germany.
- Author
-
Mohr A, Plentz A, Sieroslawski A, Pezenburg F, Koch M, Bauernfeind S, Pfeifer M, Salzberger B, and Hitzenbichler F
- Subjects
- Adult, Cross-Sectional Studies, Germany, Humans, Immunization Schedule, Vaccination, Diphtheria, Lung Diseases
- Abstract
Background: Vaccinations are among the most effective preventative healthcare measures. The aim of this cross-sectional study was to evaluate the adherence of adults with pre-existing pulmonary conditions to the national vaccination schedule and to identify reasons for poor adherence., Methods: All patients with an appointment at Donaustauf hospital between October 2019 and April 2020 were asked to bring their vaccination certificates for evaluation and to compete a questionnaire. To determine the adherence vaccination certificates and patients' comorbidities were correlated with the national recommendations of the German Standing Committee on Vaccination (STIKO)., Results: 571 (65.6%) of all patients believed that their vaccination status was up-to-date. An appropriate vaccination status according to national recommendations (STIKO) was documented as follows: tetanus 56.4% (375/665), diphtheria 43.2% (292/676), poliomyelitis 28.5% (189/662), tick-borne encephalitis 45.4% (300/659), hepatitis A 31.0% (18/58), hepatitis B 34.6% (27/78), shingles 1.2% (6/489), influenza 21.0% (125/596, season 2019/2020), measles 38.3% (31/81), rubella 33.3% (7/21), pneumococcal disease 29.5% (175/593), pertussis 54.2% (365/674) and haemophilus influenza type b 100% (1/1). Adherence to rabies (0/2), varicella (0/28), meningococcal type ACWY (0/36) and type b (0/36) was 0%. 72% of patients would follow a physician's recommendation to get vaccinated., Conclusion: Adherence to STIKO recommendations was poor. However, patients are willing to follow a physician's recommendation for vaccination., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.)
- Published
- 2021
- Full Text
- View/download PDF
47. Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone.
- Author
-
Siska PJ, Decking SM, Babl N, Matos C, Bruss C, Singer K, Klitzke J, Schön M, Simeth J, Köstler J, Siegmund H, Ugele I, Paulus M, Dietl A, Kolodova K, Steines L, Freitag K, Peuker A, Schönhammer G, Raithel J, Graf B, Geismann F, Lubnow M, Mack M, Hau P, Bohr C, Burkhardt R, Gessner A, Salzberger B, Wagner R, Hanses F, Hitzenbichler F, Heudobler D, Lüke F, Pukrop T, Herr W, Wolff D, Spang R, Poeck H, Hoffmann P, Jantsch J, Brochhausen C, Lunz D, Rehli M, Kreutz M, and Renner K
- Subjects
- Adult, COVID-19 metabolism, Cyclophilin A physiology, Fatty Acids metabolism, Female, Humans, Male, Middle Aged, Mitochondria pathology, Reactive Oxygen Species metabolism, Basigin physiology, COVID-19 immunology, Dexamethasone pharmacology, SARS-CoV-2, T-Lymphocytes metabolism
- Abstract
Metabolic pathways regulate immune responses and disrupted metabolism leads to immune dysfunction and disease. Coronavirus disease 2019 (COVID-19) is driven by imbalanced immune responses, yet the role of immunometabolism in COVID-19 pathogenesis remains unclear. By investigating 87 patients with confirmed SARS-CoV-2 infection, 6 critically ill non-COVID-19 patients, and 47 uninfected controls, we found an immunometabolic dysregulation in patients with progressed COVID-19. Specifically, T cells, monocytes, and granulocytes exhibited increased mitochondrial mass, yet only T cells accumulated intracellular reactive oxygen species (ROS), were metabolically quiescent, and showed a disrupted mitochondrial architecture. During recovery, T cell ROS decreased to match the uninfected controls. Transcriptionally, T cells from severe/critical COVID-19 patients showed an induction of ROS-responsive genes as well as genes related to mitochondrial function and the basigin network. Basigin (CD147) ligands cyclophilin A and the SARS-CoV-2 spike protein triggered ROS production in T cells in vitro. In line with this, only PCR-positive patients showed increased ROS levels. Dexamethasone treatment resulted in a downregulation of ROS in vitro and T cells from dexamethasone-treated patients exhibited low ROS and basigin levels. This was reflected by changes in the transcriptional landscape. Our findings provide evidence of an immunometabolic dysregulation in COVID-19 that can be mitigated by dexamethasone treatment.
- Published
- 2021
- Full Text
- View/download PDF
48. Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2.
- Author
-
Bauernfeind S, Salzberger B, Hitzenbichler F, Scigala K, Einhauser S, Wagner R, Gessner A, Koestler J, and Peterhoff D
- Abstract
It is not clear whether there is an association between adverse reactions and immune response after vaccination. Seven hundred and thirty-five vaccinees from our University Medical Center vaccination clinic provided information about sex, age and adverse reactions after first and second vaccination with BNT162b2. Adverse reactions were categorized into three groups: no or minor on the injection side, moderate (not further classified) and severe-defined as any symptom(s) resulting in sick leave. We chose 38 vaccinees with the most severe adverse reactions and compared their humoral and T-cell-mediated immune responses after second vaccination with those of 38 sex and age matched controls without or only minor injection-side related adverse reactions. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-receptor binding domain (RBD) IgG titers were detectable in all participants (median 5528; range 958-26,285). Men with severe adverse reactions had 1.5-fold higher median SARS-CoV-2 RBD IgG titers compared to men without adverse reactions (median 7406 versus 4793; p < 0.001). Similarly; neutralization activity was significantly higher in men with severe adverse reactions (half maximal inhibitory concentrations (IC
50 ) median 769 versus 485; p < 0.001). Reactogenicity did not influence humoral immune response in women nor T-cell-mediated immune response in any sex. To conclude; adverse reactions after vaccination with BNT162b2 do influence humoral immune response yet only in men and are not a prerequisite for a robust antibody response.- Published
- 2021
- Full Text
- View/download PDF
49. Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study.
- Author
-
Rupp M, Baertl S, Walter N, Hitzenbichler F, Ehrenschwender M, and Alt V
- Abstract
This study aims to investigate (1) microbial patterns in fracture-related infections (FRIs) in comparison to microbiological patterns of periprosthetic joint infections (PJIs), (2) the identification of effective empiric antibiotic therapy for FRIs and PJIs and (3) analysis of difficult-to-treat (DTT) pathogens. Patients treated for FRIs or PJIs from 2017 to 2020 were evaluated for pathogens detected during treatment. Antibiotic susceptibility profiles were examined with respect to broadly used antibiotics and antibiotic combinations. Resistance rates to rifampicin or fluoroquinolone were determined. A total of 81 patients with PJI and 86 with FRI were included in the study. For FRIs Staphylococcus aureus was the most common infection-causing pathogen (37.4% vs. 27.9% for PJI). Overall, there was no statistical difference in pathogen distribution ( p = 0.254). For FRIs, combinations of gentamicin + vancomycin (93.2%), co-amoxiclav + glycopeptide and meropenem + vancomycin (91.9% each) would have been effective for empiric therapy, similar to PJIs. Difficult to treat pathogens were more frequently detectable in PJIs (11.6% vs. 2.3%). Empiric therapy combinations such as gentamicin + vancomycin, co-amoxiclav + glycopeptide or meropenem + vancomycin, are effective antibiotic strategies for both FRI and PJI patients. More DTT pathogens were detectable in PJIs compared to FRIs.
- Published
- 2021
- Full Text
- View/download PDF
50. [Hygiene in ENT examination: Fluorescence study with overview of current recommendations].
- Author
-
Rohrmeier C, Schneider-Brachert W, Kühnel T, Hitzenbichler F, Holzmann T, and Bohr C
- Subjects
- Fluorescence, Humans, Disinfection, Hygiene
- Abstract
Increasing normative demands on patient safety and quality assurance measures, but also the problem of multi-resistant germs and pathogens with a high potential for infection, increase the need for hygienically correct work.In this study, hygienically relevant potential sources of contamination in ENT examinations were to be identified and possible improvement strategies examined.A complete ENT examination was performed by 5 examiners with different professional experience, whose gloves were wetted with fluorescent lotion prior to the examination. Contaminations especially on the examination unit and on the instruments were identified. The potential risk of transmission of pathogens to subsequent patients was assessed using a specially developed score. Various strategies to reduce identified contamination possibilities were developed and thought through.The score of the investigators was very high with an average of 87.4 points (±3.6). The implementation of individual hygiene measures during the examination process would lead to a significant reduction of the score and thus to an improvement in hygiene: No shaking of hands (81.8), additional disinfection of patient's chair (79.8), disinfection of important surfaces (69.8), provision of standard instruments (60.2) or all instruments (32.2), disinfection of all relevant surfaces and provision of all instruments (7.4).The results show very clearly that an ENT examination is a complex procedure from the point of view of hygiene. For reliable protection against possible transmission events, a structured bundling of hygiene measures is therefore necessary., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.